PS Ratio: 1.48

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 1.48 is 71% below its estimated 5-year average of 5.10, near the low end of its estimated 5-year range (0.95–519.41).

As of 2026-10-06T18:01:15.551Z. 8.55% below its estimated 12-month average of 1.62.

BOLT PS Ratio Metrics

P/S vs. estimated history

At 1.48, P/S is below its estimated 6-year median — higher than 10% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Bolt Biotherapeutics, Inc. (BOLT)?

The P/S ratio for BOLT stock is 1.48.

Is Bolt Biotherapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 1.48 is 71% below its estimated 5-year average of 5.10, near the low end of its estimated 5-year range (0.95–519.41).

What is the estimated TTM average P/S ratio for Bolt Biotherapeutics, Inc. (BOLT)?

The estimated TTM average P/S ratio for BOLT stock is 1.62.

What is the estimated 3Y average P/S ratio for Bolt Biotherapeutics, Inc. (BOLT)?

The estimated 3Y average P/S ratio for BOLT stock is 2.14.

What is the estimated 5Y average P/S ratio for Bolt Biotherapeutics, Inc. (BOLT)?

The estimated 5Y average P/S ratio for BOLT stock is 5.10.

Showing the most recent 260 of 1,360 data points. The chart above shows the full history.

Related Metrics